Cardinal Health, Inc.
CAH Healthcare Medical Distribution
Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow CAH
Cardinal Health, Inc. (CAH) Revenue
Cardinal Health, Inc.'s revenue for fiscal 2026 was $254.2B, up 14.2% from $222.6B in fiscal 2025. Over the past ten years it has ranged from $102.5B (fiscal 2015) to $254.2B (fiscal 2026) — the current reading is the highest in ten years. Cardinal Health, Inc. ranks 3rd of 10 Medical Distribution companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2026 | $254.2B | 14.23% |
| FY2025 | $222.6B | (1.87%) |
| FY2024 | $226.8B | 10.66% |
| FY2023 | $205.0B | 13.04% |
| FY2022 | $181.3B | 11.61% |
| FY2021 | $162.5B | 6.24% |
| FY2020 | $152.9B | 5.08% |
| FY2019 | $145.5B | 6.38% |
| FY2018 | $136.8B | 5.26% |
| FY2017 | $130.0B | 6.94% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $63.7B | 4.48% |
| Mar 2026 | $60.9B | (7.14%) |
| Dec 2025 | $65.6B | 2.53% |
| Sep 2025 | $64.0B | 6.40% |
| 42 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| MCK McKesson Corporation compare | $411.0B |
| COR Cencora, Inc. compare | $332.8B |
| CAH Cardinal Health, Inc. | $254.2B |
| HSIC Henry Schein, Inc. compare | $13.6B |
| ACH Accendra Health, Inc. compare | $2.6B |
| FOCL FocalTherics compare | $77.8M |
| COSM Cosmos Health Inc. compare | $73.7M |
| AHG Akso Health Group Sponsored ADR compare | $20.1M |
| HKPD Cellyan Biotechnology Co., Ltd compare | — |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on CAH
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement